Well… I’m sitting at home on sick leave after having had a large lump cut out of my sinuses and I’m not feeling on top for, That’s the reason that I’m giving for why none of this seems to make much sense to me…
SELECTED ARTICLES
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients. Al-Shaibani, E., et al. (2021) Clinical Lymphoma, Myeloma and Leukemia [record in progress]Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma. Bishop, M. R., et al. (2021) The New England Journal of Medicine [record in progress]Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma. Costa, L. J., et al (2021) Journal of Clinical Oncology: Jco2101935Impact of donor-derived CD34+ infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT. Czerw, T., et al. (2021) Bone Marrow Transplantation [record in progress]Safety and efficacy of prophylactic levofloxacin in pediatric and adult hematopoietic stem cell transplant patients. Gardner, J. C., et al. (2021) Transplantation and Cellular Therapy [record in progress]A decision analysis for unrelated bone marrow transplantation or immediate cord blood transplantation for patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission: Unrelated BMT or immediate CBT for Ph-negative ALL. Kako, S., et al. (2021) Transplantation and Cellular Therapy [record in progress]Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation. Nagler, A., et al. (2021) Transplantation and Cellular Therapy [record in progress]ATG and Post-transplant Cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts. Novitzky-Basso, L., et al. (2021) European Journal of Haematology [record in progress]Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical HCT with Post-Transplant Cyclophosphamide: CRS post haploidentical HCT with PTCy. Outoukesh, S., et al. (2021) Transplantation and Cellular Therapy [record in progress]
ARTICLE OF THE MONTH Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies. Luznik, L., et al. (2021) Journal of Clinical Oncology: Jco2102293PICO SUMMARY +++++ |
No comments:
Post a Comment